Dexmethylphenidate Extended Release

@article{Moen2009DexmethylphenidateER,
  title={Dexmethylphenidate Extended Release},
  author={Marit D. Moen and S. Keam},
  journal={CNS Drugs},
  year={2009},
  volume={23},
  pages={1057-1083}
}
SummaryAbstractDexmethylphenidate extended release (XR) [Focalin® XR] is a CNS stimulant indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in patients aged ≥6 years. Dexmethylphenidate contains the d-threo- enantiomer of methylphenidate. Dexmethylphenidate XR capsules have a bimodal release profile, which mimics two doses of dexmethylphenidate immediate release (IR) given 4 hours apart, and allows once-daily administration.Once-daily dexmethylphenidate XR was… Expand
8 Citations
An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations
  • 5
Analytically Confirmed Intoxication by 4-Fluoromethylphenidate, an Analog of Methylphenidate.
  • 4

References

SHOWING 1-10 OF 56 REFERENCES
Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder.
  • R. Silva, R. Muniz, +4 authors J. Wang
  • Psychology, Medicine
  • Journal of the American Academy of Child and Adolescent Psychiatry
  • 2008
  • 25
...
1
2
3
4
5
...